Researchers from the Princess Margaret Cancer Center have uncovered a new approach to treating colorectal cancer. Through the disarmament of a gene that drives self-renewal in stem cells, which also causes the root of the disease, they may be able to better treat this and other types of cancer.
A cancer-stricken Amish girl has recently gone into hiding in order to avoid chemotherapy treatment. An Ohio court recently ruled that all medical divisions pertaining to Sarah Hershberger's cancer treatment would fall due to the treatment of medical professionals and not Sarah's parents, who stoppe...
EPFL researchers have shown that copper is essential for the energy production of malignant cells, and that reducing its intake via food and water can slow down tumor growth. Copper imbalances have been associated with a number of pathological conditions, including cancer.
A recent study looks at extract from an Asian vegetable could provide therapeutic qualities to help treat head and neck cancers.
The FDA discusses tips to cut back on acrylamide, a cancer-causing chemical that may be found in foods and other products.
A recently conducted research finds that there is lack of evidence pointing towards vitamin and mineral supplements guarding people from heart diseases and cancer.
The U.S. Food and Drug Administration (FDA) has recently approved a new cancer-fighting drug known as Gazyva. This drug can be used in combination with chlorambucil in order to treat patients with untreated chronic lymphocytic leukemia (CLL), according to the company's website.
Recent findings suggest that nicotine is not the sole-addictive component in cigarette, some non-nicotinic components are also likely to trigger addiction.
A recent study found that comparatively breasts age faster than rest of the body. The UCLA researchers have identified the biological clock present in our genomes and also found a way to slow down aging.
University researchers have created a peptide (a small piece of protein), linked to a light-responsive dye, capable of switching 'on’ death pathways in cancer cells. The peptide remains inactive until exposed to external light pulses which convert it into a cell death signal.
A recent study shows that a simple blood test could help doctors detect early stages of lung and prostate cancers, with the ability to also identify the probability of recovery or recurrence after tumors are removed.